{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:28:45Z","timestamp":1772641725112,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1378\/chest.11-1881","type":"journal-article","created":{"date-parts":[[2012,8,7]],"date-time":"2012-08-07T19:01:32Z","timestamp":1344366092000},"page":"513-516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Omalizumab as a Steroid-Sparing Agent in Chronic Eosinophilic Pneumonia"],"prefix":"10.1016","volume":"142","author":[{"given":"Hatice","family":"Kaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyfettin","family":"G\u00fcm\u00fc\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ergun","family":"U\u00e7ar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Aydo\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U\u011fur","family":"Mu\u015fabak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ergun","family":"Tozkoparan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayati","family":"Bilgi\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1378\/chest.11-1881_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00005792-199809000-00001","article-title":"Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. The Groupe d'Etudes et de Recherche sur les Maladies \u201cOrphelines\u201d Pulmonaires (GERM\u201dO\u201dP)","volume":"77","author":"Marchand","year":"1998","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1378\/chest.11-1881_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1385\/CRIAI:29:1:017","article-title":"Omalizumab: other indications and unanswered questions","volume":"29","author":"Mankad","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1378\/chest.11-1881_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1378\/chest.08-2990","article-title":"Churg-strauss syndrome in patients treated with omalizumab","volume":"136","author":"Wechsler","year":"2009","journal-title":"Chest"},{"issue":"9","key":"10.1378\/chest.11-1881_bib4","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1398-9995.2009.02061.x","article-title":"Eosinophilic pneumonia in an asthmatic patient treated with omalizumab therapy: forme-fruste of Churg-Strauss syndrome?","volume":"64","author":"Cazzola","year":"2009","journal-title":"Allergy"},{"issue":"8","key":"10.1378\/chest.11-1881_bib5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/thx.2006.076513","article-title":"Apparent response to anti-IgE therapy in two patients with refractory \u201cforme fruste\u201d of Churg-Strauss syndrome","volume":"63","author":"Pabst","year":"2008","journal-title":"Thorax"},{"issue":"6","key":"10.1378\/chest.11-1881_bib6","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jaci.2006.02.028","article-title":"Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma","volume":"117","author":"Noga","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1378\/chest.11-1881_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2249.2010.04210.x","article-title":"CD23\/Fc\u03b5RII: molecular multi-tasking","volume":"162","author":"Acharya","year":"2010","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1378\/chest.11-1881_bib8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cellimm.2008.08.003","article-title":"129\/SvJ mice have mutated CD23 and hyper IgE","volume":"254","author":"Ford","year":"2009","journal-title":"Cell Immunol"},{"issue":"12","key":"10.1378\/chest.11-1881_bib9","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa070812","article-title":"Treatment of patients with the hypereosinophilic syndrome with mepolizumab","volume":"358","author":"Rothenberg","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1378\/chest.11-1881_bib10","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2010.03.028","article-title":"Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome","volume":"125","author":"Kim","year":"2010","journal-title":"J Allergy Clin Immunol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236921260467X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236921260467X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:31:38Z","timestamp":1757917898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001236921260467X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S001236921260467X"],"URL":"https:\/\/doi.org\/10.1378\/chest.11-1881","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omalizumab as a Steroid-Sparing Agent in Chronic Eosinophilic Pneumonia","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.11-1881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}